SEC Form 4 · accession 0001140361-15-037812
CytomX Therapeutics, Inc. · CTMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William Michael Kavanaugh
Officer — CSO, Head Res.&Non-Clin. Dev.
Period of report
May 7, 2015
Accepted (ET)
Oct 16, 2015 · 10:17 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001501989
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Oct 14, 2015 | P | 5,000 | $12.00 | A | 5,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $1.5749 | May 7, 2015 | A | 246,042 | A | — | Feb 8, 2025 | Common Stock | 246,042 | 246,042 | D |
| Emploiyee Stock Option (right to buy)F2 | $6.6147 | Aug 26, 2015 | A | 85,605 | A | — | Aug 25, 2025 | Common Stock | 85,605 | 85,605 | D |
Explanation of responses
- F1This option vests 25% on January 9, 2016, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, with each additional installment vesting on the last day of the month.
- F2This option vests in 48 substantially equal monthly installments starting on August 28, 2015, with each additional installment vesting on the last day of the month.
Remarks
Exhibit 24.1 - Power of Attorney (incorporated by reference to the Power of Attorney filed as Exhibit 24.1 to the Form 3 filed by the reporting person on October 7, 2015)